← All diseases
Lungs and airways
Pulmonary fibrosis (IPF)
Would you like to receive a message when there is new research on Idiopathic Pulmonary Fibrosis (IPF)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was researched — and you'll receive a notification as soon as there is new research on Pulmonary Fibrosis (IPF). View what Premium costs.
Publications (1342)
- A seven-gene panel with diagnostic and prognostic value for idiopathic pulmonary fibrosis and candidate herbal drugs identified based on these genes. (2026/01/15) ♡
- Rubiadin-1-methyl ether alleviates bleomycin induced pulmonary fibrosis. (2026/01/08) ♡
- The role of age-related genes in idiopathic pulmonary fibrosis and molecular docking analysis of their drug targets. (2026/01/05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Zone of z-scores uncertainty in pulmonary function interpretation: A proof-of-concept study from CO and NO lung diffusing capacities. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Usual Interstitial Pneumonia Spectrum: UIP, Probable UIP, and Indeterminate UIP. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. "Smoking Related Interstitial Lung Disease: Pattern Really Does Matter". (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Organizing Pneumonia Phenotype. (2026/01/01) ♡
- Pattern of interstitial lung disease in Southern India: A retrospective study. (2026/01/01) ♡
- Role of impulse oscillometry in understanding the changes in physiomechanics of respiratory system in diffuse parenchymal lung diseases. (2026/01/01) ♡
- Xiebai San mediates the NCOA2-ESR1/2 signaling pathway to intervene in interstitial pneumonia. (2026/01/01) ♡
- Short- and Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis and Muscle Loss. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Idiopathic Pulmonary Fibrosis: A Comprehensive Review of Risk Factors, Genetics, Diagnosis, and Therapeutic Approaches. (2026/01/01) ♡
- Emerging Mechanistic Links Between Fucosylation and Senescence in Lung Diseases. (2026/01/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Lung organoids as emerging models in idiopathic pulmonary fibrosis research: Current applications, challenges, and future directions. (2026/01/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The clinical meaning of the UIP pattern in fibrotic hypersensitivity pneumonitis on cryobiopsy: A multicentre retrospective study. (2025/12/31) ♡
- Patients with idiopathic pulmonary fibrosis have fatty lungs impacting respiratory physiology. (2025/12/31) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progressive fibrotic interstitial lung diseases in India: national challenges and implications for global health policies. (2025/12/31) ♡
- Adverse side-effects of antifibrotic drugs and outcome of treatment in idiopathic pulmonary fibrosis. (2025/12/31) ♡
- Significance of clinical parameters and biomarkers to predict nintedanib-induced diarrhea: an interview-based retrospective study. (2025/12/31) ♡
- Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations. (2025/12/31) ♡
- Breaking the invisible cage: social isolation and coping strategies among patients with idiopathic pulmonary fibrosis. (2025/12/30) ♡
- Elastokines are Associated with a Poor Prognosis in Idiopathic Pulmonary Fibrosis. (2025/12/30) ♡
- Lathyrol Exerts Anti-Pulmonary Fibrosis Effects by Activating PPARγ to Inhibit the TGF-β/Smad Pathway. (2025/12/30) ♡
- Qingzao Jiufei Decoction in the Regulation of TGF-β/Smad Signaling in Idiopathic Pulmonary Fibrosis. (2025/12/30) ♡
- Hypertension in idiopathic pulmonary fibrosis: evidence of immune and genetic links from clinical and genomic analyses. (2025/12/29) ♡
- Plasma apolipoprotein E protein attenuates pulmonary fibrosis through LRP1 and PLAU dual receptor-mediated TGF-β/Smad inhibition. (2025/12/29) ♡
- Gastroesophageal Reflux, Sleep-Disordered Breathing, and Outcomes in Patients With Idiopathic Pulmonary Fibrosis. (2025/12/28) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic factors in patients with interstitial lung disease treated with nintedanib: a multicenter retrospective study in Japan. (2025/12/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The intersection of liver cirrhosis and pulmonary fibrosis. (2025/12/26) ♡
- Outcomes and Toxicity of Stereotactic Radiotherapy in Non-small Cell Lung Cancer Patients With Interstitial Lung Disease: A Multicentre Cohort Study. (2025/12/26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Design of the MIST study: a double-blind, randomised, placebo-controlled phase 2b trial of pirfenidone solution for inhalation in patients with progressive pulmonary fibrosis. (2025/12/25) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Baseline characteristics from the EXCITING-ILD registry. (2025/12/25) ♡
- Evaluation of Factors Affecting Mortality in Patients with Idiopathic Pulmonary Fibrosis: A 10-Year Single-Center Experience. (2025/12/25) ♡
- Integrating Network Pharmacology, Machine Learning, and Experimental Validation to Elucidate the Mechanism of Cardamonin in Treating Idiopathic Pulmonary Fibrosis. (2025/12/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Left Atrial Reservoir Strain in Cardiovascular and Systemic Disease: Advances and Clinical Applications From Physiology to Practice. (2025/12/25) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Provoking myofibroblast death: Strategies to resolve fibrosis and remodel tumor microenvironment. (2025/12/24) ♡
- Temporal Dynamics of Pulmonary Fibrosis and Immune Dysregulation in a Collagen V-Driven Systemic Sclerosis Model. (2025/12/24) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. COVID-19 and Interstitial Lung Disease. (2025/12/23) ♡
- Identification of Ephrin type-B receptor 4 as a critical mediator of tissue fibrosis. (2025/12/22) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Neutrophils in idiopathic pulmonary fibrosis patients are phenotypically distinct from controls. (2025/12/22) ♡
- Predictors of Disease Progression in Idiopathic Pulmonary Fibrosis Under Antifibrotic Therapy: A Retrospective Study. (2025/12/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Emerging Role of METTL3 in Lung Diseases. (2025/12/21) ♡
- Efficacy and Safety of Pirfenidone in Patients with Progressive Pulmonary Fibrosis: A Retrospective Single-Center Study. (2025/12/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Rituximab in Connective Tissue Disease-Associated Interstitial Lung Disease: From Immunopathogenesis to Therapeutic Implications. (2025/12/20) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In Vivo Target Engagement Assessment of Nintedanib in a Double-Hit Bleomycin Lung Fibrosis Rat Model. (2025/12/20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Increased transient elastography-derived liver stiffness in fibrotic interstitial lung disease compared with healthy controls and its association with high-resolution computed tomography extent: a cross-sectional observational study. (2025/12/19) ♡
- Switch-like methylation of functional pathways distinguishes COPD and idiopathic pulmonary fibrosis. (2025/12/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Magnesium, Zinc and Copper in Lung Fibrosis: A Narrative Review. (2025/12/19) ♡
- TRIM2 exacerbates the advancement of idiopathic pulmonary fibrosis by modulating β-catenin and endoplasmic reticulum stress. (2025/12/18) ♡
- Exercise alveolar oxygen extraction rate reflects ventilatory efficiency and predicts outcomes in idiopathic pulmonary fibrosis. (2025/12/18) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.